Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Total Current Liabilities (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Total Current Liabilities of $41.6 million for Q4 2025, down 8.23% year-over-year from $45.4 million in Q4 2024, and down 34.82% quarter-over-quarter from $63.9 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Total Current Liabilities (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Total Current Liabilities for 4 consecutive years, with $41.6 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Current Liabilities fell 8.23% year-over-year to $41.6 million; the TTM figure through Dec 2025 stood at $41.6 million (down 8.23% YoY), while the FY2025 annual figure was $41.6 million, down 8.23% from the prior year.
  • Total Current Liabilities fell to $41.6 million in Q4 2025 per ANL's latest filing, from $63.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $312.7 million in Q4 2022 and bottomed at $41.6 million in Q4 2025.
  • Historically, Total Current Liabilities has averaged $94.6 million across 4 years, with a median of $52.0 million in 2023.
  • Annual changes were most pronounced in 2023 — Total Current Liabilities plunged 84.11% — and 2025, when it advanced 17.59%.
  • Adlai Nortye's Total Current Liabilities stood at $312.7 million in 2022, then slumped by 84.11% to $49.7 million in 2023, then retreated by 8.68% to $45.4 million in 2024, then declined by 8.23% to $41.6 million in 2025.
  • Business Quant data shows ANL's Total Current Liabilities at $41.6 million in Q4 2025, $63.9 million in Q2 2025, and $45.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.22 Mn
Dec 31, 2025 41.63 Mn
Jun 30, 2025 63.87 Mn
Dec 31, 2024 45.36 Mn
Jun 30, 2024 54.31 Mn
Dec 31, 2023 49.67 Mn
Dec 31, 2022 312.65 Mn